- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14D-1
Tender Offer Statement Pursuant to
Section 14(d)(1) of the Securities Exchange Act of 1934
(Amendment No. 5)
THERATX, INCORPORATED
(Name of Subject Company)
VENCOR, INC.
PEACH ACQUISITION CORP.
(Bidders)
COMMON STOCK, PAR VALUE $.001 PER SHARE
(Title of Class of Securities)
883384109
(CUSIP Number of Class of Securities)
Jill L. Force
Senior Vice President,
Secretary and General Counsel
Vencor, Inc.
3300 Providian Center
400 West Market Street
Louisville, Kentucky 40202
(502) 596-7300
(Name, Address, and Telephone Numbers of Person Authorized
to Receive Notices and Communications on Behalf of Bidders)
Copy to:
Joseph B. Frumkin, Esq.
Sullivan & Cromwell
125 Broad Street
New York, New York 10004
(212) 558-4000
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
<PAGE>
- -----------------------
CUSIP No. 883384109 14D-1
- -----------------------
- -----------------------------------------------------------------------------
1. NAME OF REPORTING
PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
VENCOR, INC.
61-1055020
- -----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
- -----------------------------------------------------------------------------
3. SEC USE ONLY
- -----------------------------------------------------------------------------
4. SOURCE OF FUNDS
BK
- -----------------------------------------------------------------------------
5. CHECK THE BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEM 2(e) or 2(f) |_|
- -----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- -----------------------------------------------------------------------------
7. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
APPROXIMATELY 20,564,427 SHARES OF COMMON STOCK, PAR VALUE
$.001 PER SHARE
- -----------------------------------------------------------------------------
8. CHECK THE BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES |_|
- -----------------------------------------------------------------------------
9. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
APPROXIMATELY 99%
- -----------------------------------------------------------------------------
10. TYPE OF REPORTING PERSON
CO
- -----------------------------------------------------------------------------
<PAGE>
- -----------------------
CUSIP No. 883384109 14D-1
- -----------------------
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
PEACH ACQUISITION, CORP.
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS
AF
- ------------------------------------------------------------------------------
5. CHECK THE BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEM 2(e) or 2(f) |_|
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- ------------------------------------------------------------------------------
7. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
APPROXIMATELY 20,564,427 SHARES OF COMMON STOCK, PAR VALUE
$.001 PER SHARE
- ------------------------------------------------------------------------------
8. CHECK THE BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES |_|
- ------------------------------------------------------------------------------
9. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
APPROXIMATELY 99%
- ------------------------------------------------------------------------------
10. TYPE OF REPORTING PERSON
CO
- ------------------------------------------------------------------------------
<PAGE>
This Final Amendment (this "Amendment") is filed to supplement and
amend the information set forth in the Tender Offer Statement on Schedule 14D-1
filed by Vencor, Inc. ("Vencor"), and Peach Acquisition Corp. (the "Purchaser")
on February 14, 1997, as amended by Amendment No. 1 to such Schedule dated
February 24, 1997, Amendment No. 2 to such Schedule dated March 3, 1997,
Amendment No. 3 to such Schedule dated March 10, 1997 and Amendment No. 4 to
such Schedule dated March 17, 1997 (as amended, the "Schedule 14D-1"), with
respect to shares of Common Stock, par value $.001 per share ("Shares"), of
TheraTx, Incorporated (the "Company"). Unless otherwise indicated, the
capitalized terms used herein shall have the meanings specified in the Schedule
14D-1 including the Offer to Purchase (the "Offer to Purchase") attached as
Exhibit (a)(1) thereto.
Item 6. Interest in Securities of the Subject Company.
On March 18, 1997, the Purchaser accepted for payment all of the
approximately 20,564,427 Shares which were validly tendered pursuant to the
Offer and not withdrawn, including approximately 1,451,066 Shares tendered
pursuant to Notices of Guaranteed Delivery.
Item 11. Material to be filed as Exhibits.
The list of exhibits in the Schedule 14D-1 is hereby amended and
supplemented by adding the following exhibit:
(a)(10) Press Release, dated March 18, 1997.
<PAGE>
SIGNATURE
After due inquiry and to the best of our knowledge and belief, we
certify that the information set forth in this Amendment is true, complete and
correct.
Dated: March 19, 1997
VENCOR, INC.
By:/s/ W. Bruce Lunsford
Name: W. Bruce Lunsford
Title: Chairman of the Board, President and
Chief Executive Officer
PEACH ACQUISITION CORP.
By:/s/ W. Bruce Lunsford
Name: W. Bruce Lunsford
Title: Chairman of the Board, President and
Chief Executive Officer
<PAGE>
Exhibit Index Description
- ------------- ------------------------------------------------------------
99 Exhibit (a)(10) to Scheule 14D-1 (Amendment No. 5)
Exhibit (a)(10)
Contact: AT VENCOR: AT THERATX:
W. Earl Reed, III Donald R. Myll, Sr.
Executive Vice President and Senior Vice President and
Chief Financial Officer Chief Financial Officer
(502) 596-7380 (770) 569-1840
VENCOR COMPLETES ACQUISITION OF THERATX
---------------------------------------
LOUISVILLE, Kentucky (March 18, 1997) - Vencor, Inc. (NYSE:VC) ("Vencor") today
announced that it has acquired approximately 99% of the common stock of TheraTx,
Incorporated (Nasdaq/NM:THTX) ("TheraTx") through its tender offer for the
TheraTx common stock (including shares tendered by guaranteed delivery), which
expired at 12:00 noon today. Each remaining outstanding share of TheraTx common
stock will be converted, through a merger of a wholly-owned subsidiary of Vencor
and TheraTx, into the right to receive $17.10 in cash. Vencor currently intends
to delist the common stock of TheraTx from trading on The Nasdaq Stock Market.
TheraTx combines an outcomes-oriented approach with its proprietary
information systems to provide cost-effective quality care in 216 Rehabilitation
Centers of Excellence, 28 nursing centers and 16 occupational health clinics.
Vencor operates an integrated, long-term healthcare network consisting of
38 long-term acute care hospitals and 279 nursing centers, 34 institutional
pharmacies and, through its Atria Communities affiliate, 24 independent and
assisted living communities. The Company also provides contract subacute,
rehabilitation and respiratory therapy services to nursing and subacute centers.
- END-
